Literature DB >> 25352915

VariantDB: a flexible annotation and filtering portal for next generation sequencing data.

Geert Vandeweyer1, Lut Van Laer2, Bart Loeys2, Tim Van den Bulcke3, R Frank Kooy4.   

Abstract

Interpretation of the multitude of variants obtained from next generation sequencing (NGS) is labor intensive and complex. Web-based interfaces such as Galaxy streamline the generation of variant lists but lack flexibility in the downstream annotation and filtering that are necessary to identify causative variants in medical genomics. To this end, we built VariantDB, a web-based interactive annotation and filtering platform that automatically annotates variants with allele frequencies, functional impact, pathogenicity predictions and pathway information. VariantDB allows filtering by all annotations, under dominant, recessive or de novo inheritance models and is freely available at http://www.biomina.be/app/variantdb/.

Entities:  

Year:  2014        PMID: 25352915      PMCID: PMC4210545          DOI: 10.1186/s13073-014-0074-6

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


Background

Next generation sequencing (NGS) has the power to screen a whole genome for all kinds of genetic variation in a single experiment [1]. In medical genetics, NGS has proven to be a key tool to identify disease-causing mutations in individuals with Mendelian disorders. Most studies so far have concentrated on the exome or protein coding part of the genome, which comprises only 1.5% of the complete human genome. Despite the smaller target size, whole exome sequencing (WES) typically yields over 20,000 protein altering variants per sample [2,3]. Today, several studies have proven the potential of WES to identify causal genetic defects underlying various disorders in a substantial number of patients [4-6]. As such, WES greatly reduces experimental costs while achieving high analytical power. Despite the proven utility of, and high diagnostic demand for, NGS-based assays, interpretation and filtering of the extensive variant lists is currently a labor-intensive and cumbersome task, and hampers the implementation of WES in routine diagnostics [3,4]. NGS data analysis can be subdivided into two sequential subtasks. The first task comprises quality control of the raw sequencing reads, mapping reads to a reference genome and generating a primary variant list [7]. The second stage comprises interpretation of the variants in relation to the patient’s phenotype. Several approaches are available to handle the read-to-variant stage. Commercial packages often offer all-in-one solutions such as SeqNext [8], CLCBio Genomic Workbench [9] or Illumina’s CASAVA [10]. Academic solutions on the other hand typically consist of the combination of sequential tools for specific steps in the analysis. These include tools for cleaning up the sequence (for example, FASTX-Toolkit [11], CutAdapt [12]), aligning reads to the genome (for example, Bowtie [13], BWA [14]) and variant calling (for example, samtools [15], Genome Analysis Toolkit (GATK) [16]). Out of this extensive collection of analysis options, the research community has converged on a BWA-GATK based pipeline as the preferred method, as it appears to have the highest sensitivity and specificity. Recently, the superiority of this consensus approach was corroborated by an in-depth performance analysis of several available methods [17]. Galaxy, a flexible and publicly available online platform, offers streamlined execution of consecutive processing steps to non-bioinformatics experts, thus providing a straightforward implementation of the first analysis stage [18-20]. Ideally, the second analysis stage would be able to handle identified variants of either a single sample, a family-based analysis, or a case/control study, while at the same time integrating extensive annotation with biological information and dynamic filtering. Commercial packages such as Bench Suite [21] provide turn-key solutions for variant annotation, interpretation and prioritization. However, these platforms are tailored at long-term usage in routine clinical diagnostics laboratories, and are less suitable for use in smaller laboratories or research settings that typically demand more flexible and less expensive solutions. Currently available academic software still requires the manual inspection of variants using a combination of web tools and stand-alone packages. Many of these tools were developed for specific research questions, such as either family-based [22,23] or case/control-based experiments [24], or provide broad annotation in text-based output without dynamic filtering options [23,25-28]. Other available tools provide dynamic filtering options but can only handle a limited set of annotations [29-31]. Direct integration of the first and second analysis stage, bypassing manual handling of intermediate results, is a feature currently only available in the WEP platform [32]. Finally, as both genetic and phenotypic heterogeneity appear to be an emerging theme in many genetic disorders, it is clear that WES data should be evaluated in the context of large cohorts of patients and controls [33]. Hence, online collaboration between genetic centers in a protected setting, which is available only for a limited number of current tools, provides a significant advantage [29]. To overcome the limitations of currently available solutions in the complex annotation and filtering stage of NGS data analysis, we developed VariantDB. It unifies broad annotation and flexible filtering strategies in a user-friendly online interface and at the same time provides direct integration with the semi-automatic analysis capabilities of platforms such as Galaxy. Furthermore, it allows collaboration and data protection using role-based authentication.

Implementation

Interface and database

VariantDB consists of a PHP (5.3.2) based web interface, driving a CGI (5.10.1) backend. All data are stored in a MySQL (5.1.41) database on solid state drives (Figure 1). Structurally, data are ordered in sample and variant specific tables (Additional file 1). One additional table links variants to samples and holds quality information from GATK. Variant annotations are stored in separate tables based on the annotation source. This structure optionally allows VariantDB to retrieve annotation or filtering data from multiple sources in parallel, using the Perl Parallel::ForkManager library. Further improvements in performance can be achieved by enabling Memcached. The Perl Cache::Memcached::Fast library can reduce database load by caching and preloading frequently used data in memory. Queries, sources, and documentation for all filters and annotations are stored in XML files. Additional filtering rules can be specified as separate nodes in these configuration files.
Figure 1

Schematic representation of VariantDB implementation. Depending on the expected platform load, server elements can be hosted either on a single machine (default) or on separate physical hosts. If high performance computing (HPC) infrastructure is available, annotation processes can be distributed. HPO, Human Phenotype Ontology.

Schematic representation of VariantDB implementation. Depending on the expected platform load, server elements can be hosted either on a single machine (default) or on separate physical hosts. If high performance computing (HPC) infrastructure is available, annotation processes can be distributed. HPO, Human Phenotype Ontology. A public VariantDB instance is available for academic use. Furthermore, local installation is supported through either a downloadable virtualbox application or full installation on local infrastructure. Instructions for both approaches are available in the online documentation. To keep local installations up to date, automatic updating through the web interface is possible for the local administrator.

Data import

VCF files can be imported from an FTP server, accessible using VariantDB user credentials, or directly from a Galaxy server using the VariantDB tool (Additional file 2; for installation see [34]). Imported VCF files should comply with the VCF4.0 standards. Quality annotations generated by the GATK-based genotypers [7] are extracted and stored. VariantDB provides the option to store the imported VCF file and associated BAM file. If available, direct links are presented to load VCF and BAM files into Integrative Genomics Viewer (IGV) for visualization of filtering results [35].

Annotation

Data annotation within VariantDB is available at sample and variant levels. With regard to sample annotation, family and experimental relations can be provided, which can later be applied to formulate inheritance patterns for variant filtering. Second, gender and phenotype information based on the Human Phenotype Ontology [36] is available. Finally, samples can be labeled as controls, which allow exclusion of common variants in filtering. Variant annotation is triggered by importing VCF files. Annotation proceeds by collecting variants missing a respective annotation, annotating the list of variants, and storing the results in the database. The annotation-specific tables in the database structure allow this process to be parallelized. If a high performance computing infrastructure is available, VariantDB can be configured to distribute these processes using the Perl Schedule::DRMAAc module (0.81). In total, 110 annotations are added to each variant (Table 1), taken from eight sources. The annotation engine utilizes ANNOVAR, snpEff, the Perl WWW::Mechanize library (for web tools) and a set of in-house parsers to retrieve the annotations [25,28]. All annotations are presented by checkboxes in VariantDB for inclusion into the results (Figure 2). Users can also define sets of annotations that can be loaded simultaneously.
Table 1

Summary of annotations available in VariantDB

Source tool Available annotations Reference
GATK genotypersVariant coverage, allelic ratio, genotype, Phred polymorphism, Phred genotype, quality by depth, mapping quality, ranksums, strand bias[16]
ANNOVARAllele frequencies (1KG/ESP/dbSNP), pathogenicity (dbNSFP, CADD, GERP++), segdups, genes (symbol, exon, location, effect; UCSC/RefGene/Ensembl)[28]
SnpEffVariant effect, effect impact, location, protein change, gene (Ensembl)[25]
Web toolsMutationTaster, SIFT, PROVEAN, Grantham[37-39]
Gene OntologyAssociated Gene Ontology IDs, terms, and term types. First level parental terms[40]
ClinVarLink to ClinVar, variant type, pathogenic class, class comment, affected gene and transcript, latest update, associated disease, links to external data sources, publications[41]
Gene panelsAffected gene, comments, panel name
Figure 2

Selection of annotations. Top left: sample selection box, using either a dropdown menu, or auto-completion. Top right: when raw data files are available, hyperlinks are presented to download VCF/BAM files or load the files into IGV. Bottom left: all available annotations are listed. Users can select annotations using checkboxes for inclusion into the filtering results. Bottom right: previously saved sets of annotations can be enabled at once by selecting the checkbox and pressing ‘Add Annotations’.

Summary of annotations available in VariantDB Selection of annotations. Top left: sample selection box, using either a dropdown menu, or auto-completion. Top right: when raw data files are available, hyperlinks are presented to download VCF/BAM files or load the files into IGV. Bottom left: all available annotations are listed. Users can select annotations using checkboxes for inclusion into the filtering results. Bottom right: previously saved sets of annotations can be enabled at once by selecting the checkbox and pressing ‘Add Annotations’. GATK genotyping modules provide a set of quality parameters for each identified variant. VariantDB stores the values of the allelic ratio, Phred score of the polymorphism (QUAL), Phred-based genotype quality (GQ), genotype (GT), allelic depths (AD), quality by depth (QD), mapping quality (MQ), strand bias (FS) and rank sums (BaseQRankSum, MQRankSum, ReadPosRankSum). If available, filter entries such as the VQSR tranches filter, are also stored. Minor allele frequencies (MAFs) are available from the 1000 Genomes Project (v.2012apr) and the exome sequencing project (v.esp5400.2012Jul11, v.esp6500.2013Jan22), both global and population specific [42,43]. Second, dbSNP rsIDs, MAFs and population size values are available for versions 130, 135 and 137 [44]. Starting from version 135, the clinical association label is also extracted. Transcript information is extracted in UCSC, RefSeq and Ensembl-based format. Available information includes gene symbol or ID, transcript ID in case of multiple variants, affected position on cDNA and protein level and the effect on the protein level (intron/exon, missense/synonymous/nonsense, splicing). Predictions with regard to pathogenicity are included from several tools. Using ANNOVAR, dbSNFP annotations for LRT, MutationTaster, PhyloP, PolyPhen2 and SIFT are included [45]. GERP++ [46] and CADD [47] scores are added from the respective tool data. Up-to-date scores of PROVEAN, SIFT, Grantham and MutationTaster are retrieved using the respective web tools [37,38]. Finally, the SnpEff annotations also provide an estimate of the variant impact on the protein function [25]. Two sources are provided for functional annotation. First, Gene Ontology terms and the first level parental terms associated with affected genes are provided [40]. Second, a summary of the information available in ClinVar is available [41]. This summary includes hyperlinks to the ClinVar entry of variants that exactly match or overlap the variant in the queried sample, the type of variant in ClinVar (SNP/indel), the affected gene and transcript, latest update, evidence type, pathogenicity classification and associated disease. For gene, disease and alleles listed in ClinVar, hyperlinks are provided to several external databases. Finally, users can specify additional information on inheritance, experimental validation and diagnostic classification on a per variant level.

Annotation updates

VariantDB provides two functionality layers to automatically keep annotation sources up to date. First, using scheduled execution at a frequency specified by the system administrator, third-party resources are checked for updated releases. When new data are available, all variants are re-annotated using the new release. To maintain data traceability, all discarded annotations are archived and all changes to variant annotation are logged. Finally, users are informed by email of possibly relevant novel annotations. Second, VariantDB automates the conversion between genome builds from the web interface. Upon conversion, the platform administrator needs information on the new build, including ANNOVAR, snpEff and IGV genome versions (hg19, GRC37.66 and hg19, respectively, for the current VariantDB version). Availability of the requested build is checked and, if available, all annotation tables are downloaded. Genome coordinates of currently stored variants are converted using the UCSC LiftOver tool, and failed conversions are presented to the platform administrator for manual curation [48]. Finally, all variants are re-annotated with regard to the new coordinates and users are informed. Previous genome versions remain accessible with their final annotations in read-only mode. The current genome build is always stated in the user interface. Also, when importing data from external pipelines such as galaxy, VariantDB requires the source genome build version to be passed along with the variant files, and will generate an error message on conflicting versions.

Variant filtering

VariantDB allows filtering on a combination of any of the available annotations listed in Table 1. To set filters, users select the criteria from dropdown menus (Figure 3) and optionally group them into a multi-level decision scheme (Figure 4). Successful filter settings can be saved for future usage. Next to the functional filtering criteria, parental and sibling relationships enable filtering for de novo, dominant and recessive inheritance models. Population-based variant selection can be performed on two levels. First, users can select variants that are present at least, or no more than, a specified number of times in a selection of samples. Second, genes can be selected for mutation burden by specifying the minimal or maximal number of samples containing a mutation in the same gene.
Figure 3

Selection of filters. Left: filtering criteria are organized in high-level categories. Filters are added by selecting the relevant filter and settings from dropdown menus. Numeric (for example, quality control values) or textual (for example, Gene Symbol) criteria can be added in text fields where appropriate. Right: previously saved filtering schemes can be enabled at once by selecting the checkbox and pressing ‘Apply Filter’.

Figure 4

Graphical representation of the selected filtering scheme. Individual filters can be grouped using logic AND/OR rules. Grouping and ordering is handled using a drag-and-drop interface.

Selection of filters. Left: filtering criteria are organized in high-level categories. Filters are added by selecting the relevant filter and settings from dropdown menus. Numeric (for example, quality control values) or textual (for example, Gene Symbol) criteria can be added in text fields where appropriate. Right: previously saved filtering schemes can be enabled at once by selecting the checkbox and pressing ‘Apply Filter’. Graphical representation of the selected filtering scheme. Individual filters can be grouped using logic AND/OR rules. Grouping and ordering is handled using a drag-and-drop interface. Next to general gene and population level information, users can create in silico gene panels for targeted evaluation of candidate genes. A gene panel exists of a set of RefSeq identifiers, optionally augmented with additional comments. Gene panels are private at the user level, but can be made available as a public resource to all users.

Visualisation

By default, results are presented in a tabular overview (Figure 5) with selected annotations and IGV hyperlinks [35]. VariantDB aims at presenting all information related to a variant in a compact single screen view. Alternatively, a classic, wide table format is available, presenting all annotations on a single line per variant (Additional file 3). Results can also be exported to CSV files for downstream analysis. Finally, various charts are available to review the quality or characteristics of the resulting variant set. These charts include, among others, the Tr/Tv ratio, known versus novel ratio, MAF distribution and SNP versus indel ratio.
Figure 5

Results table. For each of the resulting variants, selected annotations are presented. On top, genomic position (which is also a hyperlink to the position in IGV), and other essential variant information is provided. If relevant, annotations are grouped in sub-tables on affected feature. User-specified information related to validation and classification is presented in a separate box on the left-hand side.

Results table. For each of the resulting variants, selected annotations are presented. On top, genomic position (which is also a hyperlink to the position in IGV), and other essential variant information is provided. If relevant, annotations are grouped in sub-tables on affected feature. User-specified information related to validation and classification is presented in a separate box on the left-hand side.

Results and discussion

Integration with existing NGS data processing systems

VariantDB provides a broad annotation of the detected variants, in combination with relevant filtering schemes and seamless integration with upstream data processing by means of a dedicated Galaxy tool. Communication between Galaxy and VariantDB occurs through generic HTTP-based forms. Hence, import of VCF files into VariantDB can be implemented as the endpoint of any NGS data analysis pipeline running on high performance computing infrastructure with internet access. We have chosen to support data import for VCF files only, as this format is the current community standard for NGS data. Although any generic VCF file can be loaded into VariantDB, GATK-based variant calling (Unified Genotyper, Haplotype Caller, MuTect [16,49]) is currently regarded as the gold standard [17]. Therefore, we included specific import of various quality scores from GATK-based VCF files.

Filtering approaches

In total 110 annotations are available targeting specific aspects for selecting relevant variants. Although all annotations can be used as filtering criteria, two of the main approaches are gene-based and family/cohort-based filtering. Gene-centric information is provided according to NCBI, Ensembl and UCSC nomenclature. To guarantee optimal sensitivity, filters to select variants that affect exonic sequence (Gene Location filter) or lead to a premature stop codon (VariantType filter) are applied in a transcript-specific manner. Using this approach, all genes where a variant introduces a stop codon in at least one transcript variant are reported. Apart from unbiased filtering, users can specify a list of candidate genes to perform in silico targeted analysis (Location Information filter). In silico gene panel analysis offers a two-step analysis for molecular diagnostics. By reducing the risk of incidental findings in initial analysis, a two-step approach lowers psychological distress for patients undergoing genetic testing [50]. If no causal variants are found in the candidate genes, whole exome or whole genome data are still available for follow-up investigation. When family or cohort information is available, this information can be used to further refine the variant list. As an example, in a recessive disorder one would select homozygous variants (Genotype Composition filter) in a patient, which are present as heterozygous variants in both parents (Family Information filter). In the absence of such information, VariantDB can select for rare variants based on MAFs taken from dbSNP, the 1000 Genomes Project, the Exome Sequencing Project, or a private control cohort (Occurrence Information filter).

Ascertaining biological relevance

Although a selected filtering approach might already imply a certain biological relevance of the resulting variants (for example, de novo stop mutations), specific annotations are provided in VariantDB to further interpret the effect of a variant. First, known clinical associations are available in dbSNP as of version v135. More extensive information, however, is added from ClinVar (Clinvar Information filter) [41]. This database brings together genotype and phenotype data for known genetic variants, both SNP and structural variants, together with experimental data, links to external resources and relevant literature. Since its release in 2012, ClinVar rapidly became a reference resource for the interpretation of high throughput genetic data [51]. Second, information on the biological function of affected genes is presented based on Gene Ontology [40]. Finally, several prediction algorithms are available within VariantDB for the ascertainment of the variant pathogenicity (Mutation Effect Prediction filter). These predictions are typically based on evolutionary conservation [37,39,52], biochemical properties of the altered amino acids [53], or a combination of these [38,54]. CADD, a novel prediction algorithm, was recently described and added to VariantDB. It integrates over 60 different annotations into a single model for variant deleteriousness, showing a significantly higher performance than previous methods [47]. With ClinVar and CADD, VariantDB thus contains two state-of-the-art annotation resources to interpret the functional impact of variants, in addition to several other widely used annotation sources.

Retrospective analysis

The development of various high-throughput screening methods resulted in an ever increasing amount of biological knowledge. Due to the continuously evolving interpretational resources, researchers are faced with the need to periodically reevaluate previous experiments for novel insights. VariantDB is, to our knowledge, the only publicly available platform that has the functionality to automatically handle such retrospective analyses. It updates all third-party resources on a preset time schedule, and notifies users when novel putatively interesting annotations are available. Here, we define putatively interesting as variants with a potential high impact on protein function (for example, frameshift or nonsense), based on both the RefSeq and the more comprehensive Ensembl gene sets, or matching variants classified as clinically relevant in ClinVar.

Performance

At the time of writing, the public VariantDB server holds over 46 million variants from almost 2,000 samples, corresponding to 2.2 million unique variants. By utilizing data caching and pre-fetching of data while users are setting filters, we achieve sufficient performance to allow interactive filtering and annotation of results (Table 2). After filtering, results are presented in batches of 100 variants to the user (Figure 5).
Table 2

Performance examples of VariantDB

Sample Filters Number of resulting variants Number of annotations First run a Second run b
Exome (77 K variants) De novo, exonic , five quality thresholds859318 s6 s
Exome (78 K variants)Five quality thresholds, SnpEff high/moderate impact1,00711014 s8 s
Exome (78 K variants)Nonec 78,42311012 s11 s

aResults are retrieved from the database, and cached for future use. bResults are retrieved from cache. cNo filters are specified. As only the first 100 variants, ordered by genomic position, are initially presented, runtime is not significantly larger.

Performance examples of VariantDB aResults are retrieved from the database, and cached for future use. bResults are retrieved from cache. cNo filters are specified. As only the first 100 variants, ordered by genomic position, are initially presented, runtime is not significantly larger.

Data protection

VariantDB contains a user authentication module to protect stored data. Projects, defined as a collection of samples, can be shared with collaborators with rights ranging from read-only access to the ability to edit or delete whole projects. This online, role-based approach offers a major advantage over desktop solutions such as VarSifter or PriVar, and web-based but single-user approaches such as EVA [30,31,55]. As a centralized solution, VariantDB enables intuitive retrospective or multi-sample analysis, and collaboration between researchers from multiple laboratories. This was already successfully demonstrated in multiple published and ongoing studies [33,56-58] (Proost et al., Sommen et al., unpublished results). For an institutional setup of VariantDB, we provide private installation of the platform behind local firewalls. This can either be the deployment of a preinstalled virtual machine or full installation on private infrastructure.

Conclusions

VariantDB offers an all-in-one solution for annotation and filtering of variants obtained from NGS experiments. As summarized in Table 3, all the currently available platforms lack one or more of the essential aspects of variant interpretation present in VariantDB. It combines a broad range of annotations and filters, thereby eliminating the need for bioinformatics expertise by the user. Availability of in silico gene panel analysis reduces the risk of incidental findings, while centralized data storage enables large multi-center study designs, automated and retrospective updates of annotations and data traceability. The modularity of VariantDB offers extensibility with field-specific (for example, COSMIC for cancer research) and future (for example, ENCODE for whole genome sequencing interpretation) annotations and annotation tools in local instances. Overall, we conclude that VariantDB has a significant added value in streamlining NGS data analysis.
Table 3

Functional comparison of VariantDB with publicly available alternatives

KggSeq VariantMaster BIERapp AnsNGS WEP FamANN PriVar EVA Annotate-it VariantDB
Citation[59][60][61][62][32][23][30][31][29]
Data management
  Online--+++--+++
  Collaborative projects----+--+++
  Inter-sample relationsa +++-++++++
Gene annotations
  RefSeq annotations++++++++++
  Ensembl annotations-++--+--++
   In silico gene panels--+---+-++
Population frequencies
  Public (ESP, 1KG, dbSNP)+++-++++++
  In-house samplesb +--------+
Pathogenicity predictions
  dbNSFP(c) +-+-+++-++
  CADD---------+
  PROVEAN---------+
Clincal
  Disease information sourceGSEA-ClinVarMIM--HuGe-MIMClinVar
System implementation
  Annotation updatesd AMA..MMMAA
  Retrospective updates----.----+
  Upstream integratione ----++---+
  Alignment visualization--+-+----+

aRelations might be either specified at sample level or provided as pedigree files upon runtime. bUser-accessible sample genotypes are used to calculate a private set of MAFs. cBoth full and partial dbNSFP annotations are considered here. dA, automatic; M, manual annotation updates; or not specified (period). eDirect integration with genotyping tools or modules.

Functional comparison of VariantDB with publicly available alternatives aRelations might be either specified at sample level or provided as pedigree files upon runtime. bUser-accessible sample genotypes are used to calculate a private set of MAFs. cBoth full and partial dbNSFP annotations are considered here. dA, automatic; M, manual annotation updates; or not specified (period). eDirect integration with genotyping tools or modules.

Availability and requirements

Project Name: VariantDB Project homepage:http://www.biomina.be/app/variantdb Operating system: Ubuntu Linux Programming language: Perl, php/cgi License: GPLv3 Restrictions for non-academics: ANNOVAR license needed
  54 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Challenges and opportunities in the investigation of unexplained intellectual disability using family-based whole-exome sequencing.

Authors:  C Helsmoortel; G Vandeweyer; P Ordoukhanian; F Van Nieuwerburgh; N Van der Aa; R F Kooy
Journal:  Clin Genet       Date:  2014-10-13       Impact factor: 4.438

3.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

4.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.

Authors:  Jeremy Goecks; Anton Nekrutenko; James Taylor
Journal:  Genome Biol       Date:  2010-08-25       Impact factor: 13.583

5.  The UCSC Genome Browser database: update 2011.

Authors:  Pauline A Fujita; Brooke Rhead; Ann S Zweig; Angie S Hinrichs; Donna Karolchik; Melissa S Cline; Mary Goldman; Galt P Barber; Hiram Clawson; Antonio Coelho; Mark Diekhans; Timothy R Dreszer; Belinda M Giardine; Rachel A Harte; Jennifer Hillman-Jackson; Fan Hsu; Vanessa Kirkup; Robert M Kuhn; Katrina Learned; Chin H Li; Laurence R Meyer; Andy Pohl; Brian J Raney; Kate R Rosenbloom; Kayla E Smith; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2010-10-18       Impact factor: 16.971

6.  SNPAAMapper: An efficient genome-wide SNP variant analysis pipeline for next-generation sequencing data.

Authors:  Yongsheng Bai; James Cavalcoli
Journal:  Bioinformation       Date:  2013-10-16

7.  EVA: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics.

Authors:  Sophie Coutant; Chloé Cabot; Arnaud Lefebvre; Martine Léonard; Elise Prieur-Gaston; Dominique Campion; Thierry Lecroq; Hélène Dauchel
Journal:  BMC Bioinformatics       Date:  2012-09-07       Impact factor: 3.169

8.  WEP: a high-performance analysis pipeline for whole-exome data.

Authors:  Mattia D'Antonio; Paolo D'Onorio De Meo; Daniele Paoletti; Berardino Elmi; Matteo Pallocca; Nico Sanna; Ernesto Picardi; Graziano Pesole; Tiziana Castrignanò
Journal:  BMC Bioinformatics       Date:  2013-04-22       Impact factor: 3.169

9.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

10.  ClinVar: public archive of relationships among sequence variation and human phenotype.

Authors:  Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  24 in total

1.  Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging.

Authors:  Elisabetta Flex; Simone Martinelli; Anke Van Dijck; Andrea Ciolfi; Serena Cecchetti; Elisa Coluzzi; Luca Pannone; Cristina Andreoli; Francesca Clementina Radio; Simone Pizzi; Giovanna Carpentieri; Alessandro Bruselles; Giuseppina Catanzaro; Lucia Pedace; Evelina Miele; Elena Carcarino; Xiaoyan Ge; Chieko Chijiwa; M E Suzanne Lewis; Marije Meuwissen; Sandra Kenis; Nathalie Van der Aa; Austin Larson; Kathleen Brown; Melissa P Wasserstein; Brian G Skotko; Amber Begtrup; Richard Person; Maria Karayiorgou; J Louw Roos; Koen L Van Gassen; Marije Koopmans; Emilia K Bijlsma; Gijs W E Santen; Daniela Q C M Barge-Schaapveld; Claudia A L Ruivenkamp; Mariette J V Hoffer; Seema R Lalani; Haley Streff; William J Craigen; Brett H Graham; Annette P M van den Elzen; Daan J Kamphuis; Katrin Õunap; Karit Reinson; Sander Pajusalu; Monica H Wojcik; Clara Viberti; Cornelia Di Gaetano; Enrico Bertini; Simona Petrucci; Alessandro De Luca; Rossella Rota; Elisabetta Ferretti; Giuseppe Matullo; Bruno Dallapiccola; Antonella Sgura; Magdalena Walkiewicz; R Frank Kooy; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2019-08-22       Impact factor: 11.025

Review 2.  Settling the score: variant prioritization and Mendelian disease.

Authors:  Karen Eilbeck; Aaron Quinlan; Mark Yandell
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

3.  Identification of FBN1 gene mutations in Ukrainian Marfan syndrome patients.

Authors:  Rustam Zhurayev; Dorien Proost; Dmytro Zerbino; Viktor Fedorenko; Josephina A N Meester; Lut VAN Laer; Bart L Loeys
Journal:  Genet Res (Camb)       Date:  2016-10-11       Impact factor: 1.588

4.  Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.

Authors:  Josephina A N Meester; Laura Southgate; Anna-Barbara Stittrich; Hanka Venselaar; Sander J A Beekmans; Nicolette den Hollander; Emilia K Bijlsma; Appolonia Helderman-van den Enden; Joke B G M Verheij; Gustavo Glusman; Jared C Roach; Anna Lehman; Millan S Patel; Bert B A de Vries; Claudia Ruivenkamp; Peter Itin; Katrina Prescott; Sheila Clarke; Richard Trembath; Martin Zenker; Maja Sukalo; Lut Van Laer; Bart Loeys; Wim Wuyts
Journal:  Am J Hum Genet       Date:  2015-08-20       Impact factor: 11.025

5.  Interactive Exploration, Analysis, and Visualization of Complex Phenome-Genome Datasets with ASPIREdb.

Authors:  Powell Patrick Cheng Tan; Sanja Rogic; Anton Zoubarev; Cameron McDonald; Frances Lui; Gayathiri Charathsandran; Matthew Jacobson; Manuel Belmadani; Justin Leong; Thea Van Rossum; Elodie Portales-Casamar; Ying Qiao; Kristina Calli; Xudong Liu; Melissa Hudson; Evica Rajcan-Separovic; Me Suzanne Lewis; Paul Pavlidis
Journal:  Hum Mutat       Date:  2016-05-20       Impact factor: 4.878

6.  Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.

Authors:  Salima El Chehadeh; Wilhelmina S Kerstjens-Frederikse; Julien Thevenon; Paul Kuentz; Ange-Line Bruel; Christel Thauvin-Robinet; Candace Bensignor; Hélène Dollfus; Vincent Laugel; Jean-Baptiste Rivière; Yannis Duffourd; Caroline Bonnet; Matthieu P Robert; Rodica Isaiko; Morgane Straub; Catherine Creuzot-Garcher; Patrick Calvas; Nicolas Chassaing; Bart Loeys; Edwin Reyniers; Geert Vandeweyer; Frank Kooy; Miroslava Hančárová; Marketa Havlovicová; Darina Prchalová; Zdenek Sedláček; Christian Gilissen; Rolph Pfundt; Jolien S Klein Wassink-Ruiter; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2016-11-02       Impact factor: 4.246

7.  NOX1 Regulates Collective and Planktonic Cell Migration: Insights From Patients With Pediatric-Onset IBD and NOX1 Deficiency.

Authors:  Razieh Khoshnevisan; Michael Anderson; Stephen Babcock; Sierra Anderson; David Illig; Benjamin Marquardt; Roya Sherkat; Katrin Schröder; Franziska Moll; Sebastian Hollizeck; Meino Rohlfs; Christoph Walz; Peyman Adibi; Abbas Rezaei; Alireza Andalib; Sibylle Koletzko; Aleixo M Muise; Scott B Snapper; Christoph Klein; Jay R Thiagarajah; Daniel Kotlarz
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

8.  Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma.

Authors:  Marieke Hylebos; Ken Op de Beeck; Jenneke van den Ende; Patrick Pauwels; Martin Lammens; Jan P van Meerbeeck; Guy Van Camp
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 9.  Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications.

Authors:  Itika Arora; Trygve O Tollefsbol
Journal:  Methods       Date:  2020-09-14       Impact factor: 3.608

10.  Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.

Authors:  Ilse Van Gucht; Alice Krebsova; Birgitte Rode Diness; Steven Laga; Dave Adlam; Marlies Kempers; Nilesh J Samani; Tom R Webb; Ania A Baranowska; Lotte Van Den Heuvel; Melanie Perik; Ilse Luyckx; Nils Peeters; Pavel Votypka; Milan Macek; Josephina Meester; Lut Van Laer; Aline Verstraeten; Bart L Loeys
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.